Ben Porebski, PhD

CEO & CTO at Sortera Bio

Speaker

Dr Ben Porebski is a co-founder and the CEO/CTO of Sortera Bio, which he spun out of the MRC LMB in early 2024. As a postdoctoral scientist at the MRC LMB, he worked with Phil Holliger on developing a novel high throughput drug discovery technology called Deep Screening. Ben trained as a biochemist and molecular biologist at Monash University in Melbourne, Australia, where he worked with Ashley Buckle and Geoff Webb on engineering hyper thermostable proteins using a mixture of computational design methods, x-ray crystallography and in vitro evolution. Ben’s research spans the fields of computational and experimental protein engineering, machine learning, and technology development, typically working at the interface of multiple scientific and engineering disciplines.